Kamau Therapeutics is a clinical-stage, next-generation gene correction company harnessing high efficiency targeted gene integration to develop a new class of therapies with the aim to cure a wide range of serious and life-threatening diseases.

Komo Biosciences enables accelerated development and manufacturing of therapeutics by translating the utility of high-efficiency integrases to high-efficiency therapeutic development and manufacturing processes.